Roche Products Limited

Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW
Telephone: +44 (0)1707 366 000
Fax: +44 (0)1707 338 297
WWW: http://www.rocheuk.com
Medical Information Direct Line: +44 (0)800 032 7298
Medical Information e-mail: roche@professionalinformation.co.uk
Customer Care direct line: +44 (0)800 731 5711
Medical Information Fax: +44 (0)1748 828801
Summary of Product Characteristics last updated on the eMC: 21/09/2007
SPC Eucardic

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 21/09/2007 and displayed until Current
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 01/06/2006 and displayed until 21/09/2007
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 10 (date of (partial) revision of the text
Date of revision of text on the SPC:   27/10/05
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 7
 
Marketing Authorisation Holder change of address.
 
Section 10
 
Date of Revision of the Text changed to September 2005
Updated on 03/11/2005 and displayed until 01/06/2006
Reasons for adding or updating:
  • Removal of Black Triangle
Updated on 23/07/2004 and displayed until 03/11/2005
Reasons for adding or updating:
  • Change to section 9 - Date of Renewal of Authorisation
Updated on 20/09/2002 and displayed until 23/07/2004
Reasons for adding or updating:
  • Change to section 4.3 - Contra-indications
  • Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
  • Change to section 4.6 - Pregnancy and Lactation
  • Change to section 4.8 - Undesirable Effects
Updated on 21/12/2001 and displayed until 20/09/2002
Reasons for adding or updating:
  • Change to section 4.1 - Therapeutic Indications
  • Change to section 4.2 - Posology and Method of Administration
  • Change to section 4.3 - Contra-indications
  • Change to section 5 - Pharmacological Properties
Updated on 06/08/2001 and displayed until 21/12/2001
Reasons for adding or updating:
  • Change to section 4.2 - Posology and Method of Administration
  • Change to section 6. 5 - Nature and Contents of Container
  • Change to section 10 (date of (partial) revision of the text
Updated on 09/04/2001 and displayed until 06/08/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 11/09/2000 and displayed until 09/04/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 19/07/2000 and displayed until 11/09/2000
Reasons for adding or updating:
  • No reasons supplied
Updated on 06/09/1999 and displayed until 19/07/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   carvedilol


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk